These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29251397)

  • 1. Keeping the right track in the treatment of patients with type 2 diabetes.
    Avogaro A
    Eur J Heart Fail; 2018 Jan; 20(1):52-54. PubMed ID: 29251397
    [No Abstract]   [Full Text] [Related]  

  • 2. Does Neprilysin Inhibition Potentiate or Minimize the Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Heart Failure?
    Packer M
    J Card Fail; 2018 Feb; 24(2):109-111. PubMed ID: 29305970
    [No Abstract]   [Full Text] [Related]  

  • 3. Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus.
    Jorsal A; Wiggers H; McMurray JJV
    Endocrinol Metab Clin North Am; 2018 Mar; 47(1):117-135. PubMed ID: 29407047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
    Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R; ;
    Circulation; 2003 Dec; 108(23):2941-8. PubMed ID: 14662691
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diabetes mellitus and heart failure: epidemiology and therapy].
    Pfister R; Erdmann E
    Herz; 2008 Apr; 33(3):178-83. PubMed ID: 18568311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes worsens pulmonary diffusion in heart failure, and insulin counteracts this effect.
    Guazzi M; Brambilla R; De Vita S; Guazzi MD
    Am J Respir Crit Care Med; 2002 Oct; 166(7):978-82. PubMed ID: 12359657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's new in heart failure in the patient with type 2 diabetes?
    Camafort M
    Endocrinol Nutr; 2015; 62(7):350-5. PubMed ID: 26228800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure.
    Arturi F; Succurro E; Miceli S; Cloro C; Ruffo M; Maio R; Perticone M; Sesti G; Perticone F
    Endocrine; 2017 Sep; 57(3):464-473. PubMed ID: 27830456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes Mellitus and Heart Failure.
    Lehrke M; Marx N
    Am J Med; 2017 Jun; 130(6S):S40-S50. PubMed ID: 28526183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the association of heart failure from drug and disease: Insights from recent cardiovascular trials in type 2 diabetes mellitus.
    Peters MN; Pollock JS; Rajagopalan S
    J Diabetes Complications; 2016 Mar; 30(2):189-91. PubMed ID: 26632087
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased Risk of Heart Failure with Two Diabetes Drugs.
    Aschenbrenner DS
    Am J Nurs; 2016 Aug; 116(8):23. PubMed ID: 27466922
    [No Abstract]   [Full Text] [Related]  

  • 12. [Focusing on elderly patients and concomitant drug therapy - Diabetology for the general practitioner].
    Urban & Vogel
    MMW Fortschr Med; 2015 Apr; 157(8):38. PubMed ID: 26012680
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes and Heart Failure: A Marriage of Inconvenience.
    Mehta A; Bhattacharya S; Estep J; Faiman C
    Clin Geriatr Med; 2020 Aug; 36(3):447-455. PubMed ID: 32586474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-lowering and heart failure: risks of errors.
    van der Horst IC; Keus F
    Lancet Diabetes Endocrinol; 2015 May; 3(5):310-2. PubMed ID: 25791289
    [No Abstract]   [Full Text] [Related]  

  • 15. Are physicians neglecting the risk of heart failure in diabetic patients who are receiving sulfonylureas? Lessons from the TOSCA.IT trial.
    Packer M
    Eur J Heart Fail; 2018 Jan; 20(1):49-51. PubMed ID: 29388338
    [No Abstract]   [Full Text] [Related]  

  • 16. Type 2 diabetes mellitus and heart failure.
    Choy CK; Rodgers JE; Nappi JM; Haines ST
    Pharmacotherapy; 2008 Feb; 28(2):170-92. PubMed ID: 18225964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Sodium Glucose Cotransporter 2 Inhibitors in the Hands of Cardiologists: With Great Power Comes Great Responsibility.
    Cherney DZ; Udell JA
    Circulation; 2016 Dec; 134(24):1915-1917. PubMed ID: 27956401
    [No Abstract]   [Full Text] [Related]  

  • 18. No increased heart failure risk is reported with DPP-4 inhibitors.
    Wise J
    BMJ; 2016 Apr; 353():i2363. PubMed ID: 27118534
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incretin-based therapy in type 2 diabetes does not increase the risk of hospitalization for heart failure].
    Steurer J
    Praxis (Bern 1994); 2016 Jun; 105(13):785-6. PubMed ID: 27329712
    [No Abstract]   [Full Text] [Related]  

  • 20. Revisiting the Diabetes-Heart Failure Connection.
    Wallner M; Eaton DM; von Lewinski D; Sourij H
    Curr Diab Rep; 2018 Oct; 18(12):134. PubMed ID: 30343339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.